In this episode we spoke to Jackie Hunter, CEO of Benevolent Bio, a company that utilises machine learning and AI to find previously overlooked drug candidates within the research literature. Jackie was previously Chief Executive of the BBSRC and comes into the AI space with a wealth of experience in industrial drug discovery.
We were joined by Alok Tayi, CEO and Co-Founder of TetraScience, a Y Combinator alumni company that utilises IoT to transform how research is done. We talk about the current state of 'disconnected' research, the adoption rate of innovation in science, and how to give researchers their weekends back.
Over the past week, Entrepreneur First have staged their 7th cohort demo day in London and their first in Singapore.
OpenML seeks to make state of the art machine learning processes easily accessible and sharable.